Open Access 01-08-2019 | Epstein-Barr Virus | Letter to the Editor
Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein–Barr virus
Published in: Annals of Hematology | Issue 8/2019
Login to get access